Dr. Rubatt is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2000 Boise Ave
Loveland, CO 80538Phone+1 970-810-3894Fax+1 970-810-3897
Education & Training
UPMC Medical EducationFellowship, Gynecologic Oncology, 2008 - 2011
Duke University HospitalPost-Doctoral Fellowship, 2006 - 2008
Virginia Commonwealth University Health SystemResidency, Obstetrics and Gynecology, 2002 - 2006
Medical College of WisconsinClass of 2002
Certifications & Licensure
CO State Medical License 2014 - 2025
NC State Medical License 2006 - 2015
PA State Medical License 2008 - 2012- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- Fellow (FACOG) American Congress of Obstetricians and Gynecologists
Publications & Presentations
PubMed
- 9 citationsDifferential Angiogenic Gene Expression in TP53 Wild-Type and Mutant Ovarian Cancer Cell Lines.Brittany A. Davidson, Jennifer M. Rubatt, David L. Corcoran, Deanna K. Teoh, Marcus Q. Bernardini
Frontiers in Oncology. 2014-06-20 - 21 citationsCholine phosphate cytidylyltransferase-α is a novel antigen detected by the anti-ERCC1 antibody 8F1 with biomarker value in patients with lung and head and neck squamo...Alec Vaezi, Gerold Bepler, Nikhil R. Bhagwat, Agnes Malysa, Jennifer M. Rubatt
Cancer. 2014-06-15 - 35 citationsPre-treatment tumor expression of ERCC1 in women with advanced stage epithelial ovarian cancer is not predictive of clinical outcomes: A gynecologic oncology group studyJennifer M. Rubatt, Kathleen M. Darcy, Chunqiao Tian, Franco M. Muggia, Rajiv Dhir
Gynecologic Oncology. 2012-05-01
Press Mentions
New Study Touts Aspirin for Ovarian Ca PreventionNovember 12th, 2018
Some Cancer Drugs Are in Short Supply, Putting Patients' Care at Risk. Here's WhyJune 16th, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
